Big Pharma earnings kick off; Third-round IRA drugs selected; Hengrui’s trailblazing moment; and more
Big Pharma earnings kick off; Third-round IRA drugs selected; Hengrui’s trailblazing moment; and more
Big Pharma earnings kick off; Third-round IRA drugs selected; Hengrui’s trailblazing moment; and more
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.